Effects of the specific a42 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice

Psychopharmacology

Volumn 223, Issue 2, 2012, Pages 159-168

  Tobey, K M ^a   Walentiny, D M ^a   Wiley, J L ^b   Carroll, F I ^b   Damaj, M I ^a   Azar, M R ^c   Koob, G F ^c   George, O ^c   Harris, L S ^a   Vann, R E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Conditioned place preference; Drug discrimination; Intracranial self stimulation; Nicotine; Self administration

Indexed keywords

2 FLUORO 3 (4 NITROPHENYL) DESCHLOROEPIBATIDINE; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT; RTI 7527 102; SODIUM CHLORIDE; UNCLASSIFIED DRUG; 2 FLUORO 3 (4 NITROPHENYL)DESCHLOROEPIBATIDINE; 2-FLUORO-3-(4-NITROPHENYL)DESCHLOROEPIBATIDINE; FUSED HETEROCYCLIC RINGS; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; PYRIDINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG POTENCY; DRUG SELF ADMINISTRATION; DRUG STRUCTURE; ELECTRODE; ELECTROSTIMULATION; FOREBRAIN; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; SELF STIMULATION; STEREOTAXIS; TOBACCO DEPENDENCE; TRAINING; TREATMENT RESPONSE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; INSTITUTE FOR CANCER RESEARCH MOUSE; INSTRUMENTAL CONDITIONING; LONG EVANS RAT; METABOLISM; PERCEPTIVE DISCRIMINATION; REWARD; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; BICYCLO COMPOUNDS, HETEROCYCLIC; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED ICR; MOLECULAR STRUCTURE; NICOTINE; NICOTINIC ANTAGONISTS; PYRIDINES; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, NICOTINIC; REWARD; SELF ADMINISTRATION; SELF STIMULATION; SPECIES SPECIFICITY;

EID: 84866742604     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2703-3     Document Type: Article

References (64)

1. Abdrakhmanova GR, Damaj MI, Carroll FI, Martin BR (2006) 2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine is a novel potent competitive antagonist of human neuronal alpha4beta2 nAChRs. Mol Pharmacol 69:1945-1952
2. Benowitz NL (2009) Pharmacology of nicotine: addiction, smokinginduced disease, and therapeutics. Annu Rev Pharmacol Toxicol 49:57-71
3. Biala G, Staniak N, Budzynska B (2010) Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats. Naunyn Schmiedebergs Arch Pharmacol 381:361-370
4. Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, Hoffman A, Perkins KA, Sved AF (2001) Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 70:515-530
5. Cannady R, Weir R, Wee B, Gotschlich E, Kolia N, Lau E, Brotherton J, Levin ED (2009) Nicotinic antagonist effects in the mediodorsal thalamic nucleus: regional heterogeneity of nicotinic receptor involvement in cognitive function. Biochem Pharmacol 78:788-794
6. Carroll FI (2004) Epibatidine structure-activity relationships. Bioorg Med Chem Lett 14:1889-1896
7. Clark MS (1969) Self-administered nicotine solutions preferred to placebo by the rat. Br J Pharmacol 35:367P
8. Colpaert FC (1999) Drug discrimination in neurobiology. Pharmacol Biochem Behav 64:337-345
9. Corrigall WA, Coen KM (1989) Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl) 99:473-478
10. Damaj MI, Kao W, Martin BR (2003) Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. J Pharmacol Exp Ther 307:526-534
11. Damaj MI, Wiley JL, Martin BR, Papke RL (2005) In vivo characterization of a novel inhibitor of CNS nicotinic receptors. Eur J Pharmacol 521:43-48
12. Davis JA, Gould TJ (2006) The effects of DHBE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice. Psychopharmacology (Berl) 184:345-352
13. Davis JA, Kenney JW, Gould TJ (2007) Hippocampal alpha4beta2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning. J Neurosci 27:10870-10877
14. Donny EC, Caggiula AR, Knopf S, Brown C (1995) Nicotine selfadministration in rats. Psychopharmacology (Berl) 122:390-394
15. Easterling KW, Holtzman SG (1997) Intracranial self-stimulation in rats: sensitization to an opioid antagonist following acute or chronic treatment with mu opioid agonists. J Pharmacol Exp Ther 281:188-199
16. Eissenberg T, Griffiths RR, Stitzer ML (1996) Mecamylamine does not precipitate withdrawal in cigarette smokers. Psychopharmacology (Berl) 127:328-336
17. Epping-Jordan MP, Picciotto MR, Changeux JP, Pich EM (1999) Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration inmutantmice. Psychopharmacology (Berl) 147:25-26
18. Fudala PJ, Teoh KW, Iwamoto ET (1985) Pharmacologic characterization of nicotine-induced conditioned place preference. Pharmacol Biochem Behav 22:237-241
19. George O, Ghozland S, Azar MR, Cottone P, Zorrilla EP, Parsons LH, O'Dell LE, Richardson HN, Koob GF (2007) CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine selfadministration in nicotine-dependent rats. Proc Natl Acad Sci U S A 104:17198-17203
20. George O, Lloyd A, Carroll FI, Damaj MI, Koob GF (2011) Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration. Psychopharmacology (Berl) 213:715-722
21. Goldberg SR, Spealman RD, Goldberg DM (1981) Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science 214:573-575
22. Gommans J, Stolerman IP, Shoaib M (2000) Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL/6 J mice. Neuropharmacology 39:2840-2847
23. Gotti C, Guiducci S, Tedesco V, Corbioli S, Zanetti L, Moretti M, Zanardi A, Rimondini R, Mugnaini M, Clementi F, Chiamulera C, Zoli M(2010) Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2 receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. J Neurosci 30:5311-5325
24. Grabus SD, Martin BR, Brown SE, Damaj MI (2006) Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists. Psychopharmacology (Berl) 184:456-463
25. Grady SR, Wageman CR, Patzlaff NE, Marks MJ (2012) Low concentrations of nicotine differentially desensitize nicotinic acetylcholine receptors that include alpha5 or alpha6 subunits and that mediate synaptosomal neurotransmitter release. Neuropharmacology 62:1935-1943
26. Grottick AJ, Trube G, Corrigall WA, Huwyler J, Malherbe P, Wyler R, Higgins GA (2000) Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. J Pharmacol Exp Ther 294:1112-1119
27. Henningfield JE, Goldberg SR (1983) Nicotine as a reinforcer in human subjects and laboratory animals. Pharmacol Biochem Behav 19:989-992
28. Huston-Lyons D, Kornetsky C (1992) Effects of nicotine on the threshold for rewarding brain stimulation in rats. Pharmacol Biochem Behav 41:755-759
29. Hyytia P, Schulteis G, Koob GF (1996) Intravenous heroin and ethanol self-administration by alcohol-preferring AA and alcoholavoiding ANA rats. Psychopharmacology (Berl) 125:248-254
30. James JR, Villanueva HF, Johnson JH, Arezo S, Rosecrans JA (1994) Evidence that nicotine can acutely desensitize central nicotinic acetylcholinergic receptors. Psychopharmacology (Berl) 114:456-462
31. Kota D, Martin BR, Robinson SE, Damaj MI (2007) Nicotine dependence and reward differ between adolescent and adult male mice. J Pharmacol Exp Ther 322:399-407
32. Levin ED, Bradley A, Addy N, Sigurani N (2002) Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory. Neuroscience 109:757-765
33. Mao D, Perry DC, Yasuda RP, Wolfe BB, Kellar KJ (2008) The alpha4beta2alpha5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo. J Neurochem 104:446-456
34. Marubio LM, del Mar Arroyo-Jimenez M, Cordero-Erausquin M, Lena C, Le Novere N, de Kerchove d'Exaerde A, Huchet M, Damaj MI, Changeux JP (1999) Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398:805-810
35. McGranahan TM, Patzlaff NE, Grady SR, Heinemann SF, Booker TK (2011) α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief. J Neurosci 31:10891-10902
36. Morrison CF, Stephenson JA (1969) Nicotine injections as the conditioned stimulus in discrimination learning. Psychopharmacologia 15:351-360
37. National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington
38. Nemeth-Coslett R, Henningfield JE, O'Keeffe MK, Griffiths RR (1986) Effects of mecamylamine on human cigarette smoking and subjective ratings. Psychopharmacology (Berl) 88:420-425
39. O'Dell LE, Khroyan TV (2009) Rodent models of nicotine reward: what do they tell us about tobacco abuse in humans? Pharmacol Biochem Behav 91:481-488
40. Olds ME, Domino EF (1969) Comparison of muscarinic and nicotinic cholinergic agonists on self-stimulation behavior. J Pharmacol Exp Ther 166:189-204
41. Paterson NE, Markou A (2004) Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats. Psychopharmacology (Berl) 173:64-72
42. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic, San Diego
43. Philibin SD, Vann RE, Varvel SA, Covington HE 3rd, Rosecrans JA, James JR, Robinson SE (2005) Differential behavioral responses to nicotine in Lewis and Fischer-344 rats. Pharmacol Biochem Behav 80:87-92
44. Picciotto MR, Caldarone BJ, Brunzell DH, Zachariou V, Stevens TR, King SL (2001) Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. Pharmacol Ther 92:89-108
45. Picciotto MR, Addy NA, Mineur YS, Brunzell DH (2008) It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol 84:329-342
46. Pomerleau CS, Pomerleau OF, Majchrzak MJ (1987) Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level. Psychopharmacology (Berl) 91:391-393
47. Raybuck JD, Gould TJ (2009) Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice -a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors. Eur J Neurosci 29:377-387
48. Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD 3rd, Wi l liams KE (2007) Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52:985-994
49. Sagara H, Kitamura Y, Yae T, Shibata K, Suemaru K, Sendo T, Araki H, Gomita Y (2008) Nicotinic acetylcholine alpha4beta2 receptor regulates the motivational effect of intracranial self stimulation behavior in the runway method. J Pharmacol Sci 108:455-461
50. Shoaib M, Schindler CW, Goldberg SR (1997) Nicotine selfadministration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology (Berl) 129:35-43
51. Shoaib M, Zubaran C, Stolerman IP (2000) Antagonism of stimulus properties of nicotine by dihydro-beta-erythroidine (DHbetaE) in rats. Psychopharmacology (Berl) 149:140-146
52. Shoaib M, Gommans J, Morley A, Stolerman IP, Grailhe R, Changeux JP (2002) The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology 42:530-539
53. Smith JW, Mogg A, Tafi E, Peacey E, Pullar IA, Szekeres P, Tricklebank M (2007) Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat. Psychopharmacology (Berl) 190:157-170
54. Spiller K, Xi ZX, Li X, Ashby CR Jr, Callahan PM, Tehim A, Gardner EL (2009) Varenicline attenuates nicotine-enhanced brainstimulation reward by activation of alpha4beta2 nicotinic receptors in rats. Neuropharmacology 57:60-66
55. Stolerman IP, Goldfarb T, Fink R, JarvikME (1973) Influencing cigarette smoking with nicotine antagonists. Psychopharmacologia 28:247-259
56. Stolerman IP, Chandler CJ, Garcha HS, Newton JM (1997) Selective antagonism of behavioural effects of nicotine by dihydro-betaerythroidine in rats. Psychopharmacology (Berl) 129:390-397
57. Stolerman IP, Naylor C, Elmer GI, Goldberg SR (1999) Discrimination and self-administration of nicotine by inbred strains of mice. Psychopharmacology (Berl) 141:297-306
58. US Department of Health and Human Services (2004) The health consequences of smoking: a report of the surgeon general. US Department of Health and Human Services, Atlanta
59. Vann RE, Tobey KM, Lobe SL, Kipps B, Kwilasz AJ, Aceto MD, Harris LS (2011) Varenicline does not alter brain stimulation reward thresholds and reverses nicotine-facilitated thresholds in rats. Drug Development Res 72:310-314
60. Walters CL, Brown S, Changeux JP, Martin B, Damaj MI (2006) The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl) 184:339-344
61. Watkins SS, Epping-Jordan MP, Koob GF, Markou A (1999) Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol Biochem Behav 62:743-751
62. Wiley JL, Lavecchia KL, Martin BR, Damaj MI (2002) Nicotine-like discriminative stimulus effects of bupropion in rats. Exp Clin Psychopharmacol 10:129-135
63. Xi ZX, Spiller K, Gardner EL (2009) Mechanism-based medication development for the treatment of nicotine dependence. Acta Pharmacol Sin 30:723-739
64. Young R, Glennon RA (2002) Nicotine and bupropion share a similar discriminative stimulus effect. Eur J Pharmacol 443:113-118